国内外不同剂型盐酸哌甲酯治疗ADHD的现状
The Current Status of Different Formulations of Methylphenidate Hydrochloride in the Treatment of ADHD Both Domestically and Internationally
DOI: 10.12677/pi.2025.144030, PDF,    科研立项经费支持
作者: 徐 磊, 蒲昭霞, 邓军洋, 易 媛：成都高新西南儿童康复医院发育行为科，四川 成都；陈小璐*：四川大学华西第二医院小儿神经科/出生缺陷与相关妇儿疾病教育部重点实验室，四川 成都;发育与妇儿疾病四川省重点实验室，四川 成都；刘 芳：四川大学华西第二医院心理健康中心，四川 成都
关键词: 盐酸哌甲酯；注意缺陷多动障碍；剂型；临床研究；Methylphenidate Hydrochloride； Attention Deficit Hyperactivity Disorder； Dosage Form； Clinical Study
摘要: 注意缺陷多动障碍(ADHD)是一种常见的儿童神经发育障碍，盐酸哌甲酯作为治疗ADHD的一线药物，有多种剂型。本文综述国内外不同剂型盐酸哌甲酯治疗ADHD的研究现状，包括其药理作用、临床疗效、安全性、药物经济学以及患者依从性等方面，以期为临床合理用药提供参考。
Abstract: Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children, and methylphenidate hydrochloride, as a first-line drug for treating ADHD, has multiple formulations. This article reviews the current research status of different formulations of methylphenidate hydrochloride in the treatment of ADHD at home and abroad, including its pharmacological effects, clinical efficacy, safety, pharmacoeconomics, and patient compliance, in order to provide reference for rational drug use in clinical practice.
文章引用：徐磊, 陈小璐, 刘芳, 蒲昭霞, 邓军洋, 易媛. 国内外不同剂型盐酸哌甲酯治疗ADHD的现状[J]. 药物资讯, 2025, 14(4): 262-268. https://doi.org/10.12677/pi.2025.144030

参考文献

[1] Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L. and Alati, R. (2023) The Global Prevalence of Attention Deficit Hyperactivity Disorder in Children and Adolescents: An Umbrella Review of Meta-Analyses. Journal of Affective Disorders, 339, 860-866. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, T., Liu, K., Li, Z., Xu, Y., Liu, Y., Shi, W., et al. (2017) Prevalence of Attention Deficit/Hyperactivity Disorder among Children and Adolescents in China: A Systematic Review and Meta-Analysis. BMC Psychiatry, 17, Article No. 32. [Google Scholar] [CrossRef] [PubMed]
[3] Challman, T.D. and Lipsky, J.J. (2000) Methylphenidate: Its Pharmacology and Uses. Mayo Clinic Proceedings, 75, 711-721. [Google Scholar] [CrossRef] [PubMed]
[4] Jaeschke, R.R., Sujkowska, E. and Sowa-Kućma, M. (2021) Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Adults: A Narrative Review. Psychopharmacology, 238, 2667-2691. [Google Scholar] [CrossRef] [PubMed]
[5] Childress, A.C., Komolova, M. and Sallee, F.R. (2019) An Update on the Pharmacokinetic Considerations in the Treatment of ADHD with Long-Acting Methylphenidate and Amphetamine Formulations. Expert Opinion on Drug Metabolism & Toxicology, 15, 937-974. [Google Scholar] [CrossRef] [PubMed]
[6] Biederman, J., Mick, E. and Faraone, S.V. (2017) Advances in the Treatment of Attention—Deficit Hyperactivity Disorder in Adults. CNS Spectrums, 22, 250-260.
[7] 汤卫红, 郑毅. 注意力缺陷多动障碍治疗进展[J]. 中国心理卫生杂志, 2018, 32(10): 821-824.
[8] Pelham, W.E., Waschbusch, D.A., Gnagy, E.M., et al. (2016) Treatment of ADHD in Children and Adolescents: A Comparative Meta-Analysis. Journal of Clinical Child & Adolescent Psychology, 45, 245-266.
[9] 吴志霞, 李淑清. 盐酸哌甲酯缓释片治疗儿童注意力缺陷多动障碍的临床观察[J]. 中国药业, 2019, 28(14): 67-69.
[10] Arnold, L.E., Hodgkins, P., Caci, H., et al. (2018) Effectiveness of Methylphenidate for Attention—Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies. CNS Drugs, 32, 625-645.
[11] Faraone, S.V., Biederman, J. and Mick, E. (2017) The Science of Attention—Deficit Hyperactivity Disorder. Psychiatric Clinics of North America, 40, 509-525.
[12] Citrome, L., Zeni, C.M. and Correll, C.U. (2019) Patches: Established and Emerging Transdermal Treatments in Psychiatry. The Journal of Clinical Psychiatry, 80, Article 21174.
[13] Coghill, D.R., Seth, S., Banaschewski, T., et al. (2019) Methylphenidate for Attention Deficit Hyperactivity Disorder in Children and Adolescents: A Cochrane Systematic Review and Meta-Analysis Update to Include Trials Published up to December 2017. Evidence-Based Child Health, 14, 1-22.
[14] 郑毅, 孙洪强. 儿童注意缺陷多动障碍治疗策略[J]. 中国心理卫生杂志, 2017, 31(5): 311-314.
[15] Hodgkins, P., Arnold, L.E., Caci, H., et al. (2017) A Systematic Review of the Effectiveness of Methylphenidate in Reducing the Core Symptoms of Attention—Deficit/Hyperactivity Disorder in Children and Adolescents. CNS Drugs, 31, 865-889.
[16] 孙洪强, 郑毅. 盐酸哌甲酯治疗注意缺陷多动障碍的研究进展[J]. 中国新药杂志, 2018, 27(15): 1729-1732.
[17] Faraone, S.V., Asherson, P., Banaschewski, T., et al. (2020) Attention—Deficit/Hyperactivity Disorder. Nature Reviews Disease Primers, 6, 1-23.
[18] 李文霞, 张华. 盐酸哌甲酯不同剂型治疗ADHD的药物经济学评价[J]. 中国药房, 2020, 31(18): 2177-2180.
[19] Taylor, E., Dopfner, A., Döpfner, A., et al. (2018) European Clinical Guidelines for Hyperkinetic Disorder—The European ADHD Guidelines Group (EAGG) Treatment Recommendations. European Child & Adolescent Psychiatry, 27, 1-24.